Published in
Elsevier, The Lancet Infectious Diseases, 1(17), p. 58-67
DOI: 10.1016/s1473-3099(16)30314-0
Links
Tools
Meningococcal serogroup B-specific responses after vaccination with bivalent rLP2086: 4 year follow-up of a randomised, single-blind, placebo-controlled, phase 2 trial
Journal article published in 2017 by
Helen S. Marshall 
,
Peter C. Richmond ,
Johannes Beeslaar,
Qin Jiang,
Kathrin U. Jansen,
Maria Garcés-Sánchez,
Federico Martinón-Torres ,
Leszek Szenborn,
Jacek Wysocki,
Joseph Eiden,
Shannon L. Harris,
Thomas R. Jones,
Su-San Lee,
John L. Perez
,
Peter C. Richmond ,
Johannes Beeslaar,
Qin Jiang,
Kathrin U. Jansen,
Maria Garcés-Sánchez,
Federico Martinón-Torres ,
Leszek Szenborn,
Jacek Wysocki,
Joseph Eiden,
Shannon L. Harris,
Thomas R. Jones,
Su-San Lee,
John L. Perez
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 